Publication | Open Access
Chinese medicine for residual symptoms of COVID-19 recovered patients (long COVID)—A double-blind, randomized, and placebo-controlled clinical trial protocol
12
Citations
8
References
2023
Year
[ClinicalTrials.gov], identifier [NCT04924881].
| Year | Citations | |
|---|---|---|
Page 1
Page 1